A new study published in Molecular Psychiatry reveals that the biological underpinnings of autism and ADHD may transcend ...

Congenital Heart Disease (CHD) is one of the most common birth defects, affecting approximately 1% of live births globally and accounting for more than 4.18 million cases in children under five1.

Sahajanand Medical Technologies (SMT) is using its Cocoon Occluder devices to treat congenital heart defects like atrial septal defect and patent foramen ovale. These minimally invasive devices ...

Narayana Health City has successfully performed robotic-assisted surgeries for ventricular septal defects in children, enhancing recovery with precision techniques and minimizing scars.

Encore Medical aims to raise $17.25M in IPO funding for FDA heart device trials. Click here to read the latest analysis on ...

BOSTON, Oct. 24, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., the makers of the Barricaid® Annular Closure Device, announced today that the American Medical Association (AMA) has published a new ...

The American Medical Association released its CPT 2026 code set, which includes the new CPT code 63032 fr bone-anchored annular closure, Intrinsic Therapeutics said Oct. 24. The new add-on CPT code ...

Courtesy of Intrinsic Therapeutics, Inc. BOSTON, MA – October 24, 2025 (Via PR NewsWire) – Intrinsic Therapeutics, Inc., the makers of the Barricaid® Annular Closure Device, announced today that the ...

An investigational, suture-based large bore closure device intended to deliver fast and reliable vascular closure MENLO PARK, Calif., Oct. 23, 2025 /PRNewswire/ -- Cordis-X today announced that it has ...

A novel biodegradable patent foramen ovale (PFO) closure device, which fully degrades within 24 months following implantation, demonstrated noninferiority to the conventional nitinol device for both ...